Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. It offers medicines and preparations used to treat skin diseases, skin creams, and skin care products; respiratory, central nervous, digestive, and musculoskeletal system medicines; urinary and reproductive system drugs; disinfectants; and various therapeutic medicines and preparations, including sexual system drugs, diabetes, cardiovascular drugs, anti-infective drugs, anti-parasitic drugs, pain relievers, antiseptics, and women’s and men’s health drugs in the form of creams, rolls, masks, ointments, syrups, lotions, capsules, gels, hand sanitizers, tonics, mouthwashes, soaps, solutions, sprays, scrubs, topical solutions, and tablets. The company also provides contract manufacturing services. In addition, it specializes in cosmetic, health products and nutritional supplements. The company also exports its products. It offers its products under various brands, including Alpha Plus, Avalon Care, Avogen, AVOMEB, AVOCOM-M, eZ Care, Rotavex, AVOHEX PLUS, AVODY PLUS, Avalone povidone Iodine MW, AVOGAIN, Rhinese and Avogain, Cortrief NS, Rolenium, Avocom NS, Broncast, and Xibax, as well as AvalonActiv, Exxara, Avotrene, Amodip, Tavflox, Virecta, Evoka, EX Clean, Amaglime, Lyrgaba, Avocin, Avialis, and the Candan. The company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006. Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.